Description: Gross Domestic Product (GDP) has been our chosen metric for growth since the Great Depression, but expectations are for lower GDP growth going forward than we are accustomed to. Its two components, population and productivity, face headwinds—population from a declining birth rate and longevity, and productivity from increased climate events, energy costs, global conflict and raw materials shortages. Comparing demographic results from the U.S., China and Nigeria, representing countries with varying population growth rates, illustrates the potential economic growth issues of aging populations and high dependency ratios. The demographic challenges can be turned into opportunities to broaden prosperity; productivity can be improved by providing a level playing field and helping those in the lowest socioeconomic classes find opportunities. These topics and more will be discussed and enhance foresight about them.

Description: "Direct medical costs for cancer care topped $209 billion nationally in 2020, accounting for a significant proportion of all health care expenditures in the U.S. Indirect costs are also significant, encompassing loss of productivity, wages, leisure time and decreased quality of life. The way cancer programs deliver and are reimbursed for care is rapidly changing. As the cost of cancer care continues to rise, several new value-based care programs - both public and private - have attempted to curb these rising costs. Learn about the current landscape of VBC oncology programs, several key challenges and opportunities with oncology analytics, as well as anticipated evolution of cancer care in the near future. Topics include: Current VBC oncology landscape, including a more detailed discussion on CMS' latest oncology program, Enhancing Oncology Model (EOM) Discussion on current challenges and opportunities with oncology analytics, including some advanced methodologies that have been developed based on documented clinical pathways to better understand cost drivers Future state of oncology care including emerging pharmaceuticals and novel therapies, personalized care regimens, and other clinical innovations"

Description: Learn more about improving the modelling of individual decisions.

Description: Learn more about improving the modelling of individual decisions. This paper explains the concepts of hyperbolic discounting and provides a tool for improving the modelling of individual decisions.